{"id":109,"date":"2014-01-20T18:14:21","date_gmt":"2014-01-20T18:14:21","guid":{"rendered":"https:\/\/ananyajainblog.wordpress.com\/2014\/01\/20\/japan-approves-taked-pharmaceuticals-nda-to-treat"},"modified":"2016-10-29T21:27:03","modified_gmt":"2016-10-29T21:27:03","slug":"japan-approves-taked-pharmaceuticals-nda-to-treat","status":"publish","type":"post","link":"http:\/\/www.jainananya.com\/blog\/2014\/01\/20\/japan-approves-taked-pharmaceuticals-nda-to-treat\/","title":{"rendered":"Japan approves Taked Pharmaceuticals NDA to treat HL or ALCL"},"content":{"rendered":"<p>The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Takeda Pharmaceutical\u2019s new drug application (NDA) of Adcetris (brentuximab vedotin) 50mg intended to treat patients with CD30 positive relapsed or refractory hodgkin lymphoma (HL) or relapsed or refractory anaplastic large cell lymphoma (ALCL).<\/p>\n<p>Takeda head of the Oncology Therapeutic Area Unit Michael Vasconcelles said, \u201cThis approval brings us a step closer to providing a new treatment option to patients in Japan with relapsed or refractory HL and relapsed or refractory ALCL.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Takeda Pharmaceutical\u2019s new drug application (NDA) of Adcetris (brentuximab vedotin) 50mg intended to treat patients with CD30 positive relapsed or refractory hodgkin lymphoma (HL) or relapsed or refractory anaplastic large cell lymphoma (ALCL). Takeda head of the Oncology Therapeutic Area Unit Michael Vasconcelles said,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":231,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[9],"class_list":["post-109","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-httpregulatoryaffairs-pharmaceutical-business-review-comnewstakedas-nda-of-lymphoma-drug-adcetris-50mg-gets-approval-in-japan-200114-41"],"_links":{"self":[{"href":"http:\/\/www.jainananya.com\/blog\/wp-json\/wp\/v2\/posts\/109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.jainananya.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.jainananya.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.jainananya.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.jainananya.com\/blog\/wp-json\/wp\/v2\/comments?post=109"}],"version-history":[{"count":1,"href":"http:\/\/www.jainananya.com\/blog\/wp-json\/wp\/v2\/posts\/109\/revisions"}],"predecessor-version":[{"id":232,"href":"http:\/\/www.jainananya.com\/blog\/wp-json\/wp\/v2\/posts\/109\/revisions\/232"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.jainananya.com\/blog\/wp-json\/wp\/v2\/media\/231"}],"wp:attachment":[{"href":"http:\/\/www.jainananya.com\/blog\/wp-json\/wp\/v2\/media?parent=109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.jainananya.com\/blog\/wp-json\/wp\/v2\/categories?post=109"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.jainananya.com\/blog\/wp-json\/wp\/v2\/tags?post=109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}